Call us today for help! 214-380-2134
FDA Approval of VT3989 for Mesothelioma The FDA approval of VT3989 for mesothelioma is a major milestone in the fight against this aggressive cancer. For decades, treatment options were limited, and survival outcomes remained poor. Now, patients who have exhausted standard therapies have renewed hope thanks to this first-in-class therapy targeting the Hippo signaling pathway, …
Mesothelioma, a rare and aggressive cancer caused by asbestos exposure, has long posed challenges for early detection and effective treatment. Its symptoms often remain hidden until advanced stages, limiting treatment options and outcomes. Researchers at the Mayo Clinic have developed a new blood test that identifies unique DNA patterns specific to mesothelioma, offering an improved …
The U.S. Surgeon General, on November 19, 2024, issued a new critical warning about the persistent health risks of lung cancer, underscoring the role of tobacco and environmental toxins like asbestos and radon as primary causes. Despite decades of progress in reducing smoking rates and secondhand smoke exposure, these gains have not been equitably shared …
The former W.R. Grace & Company/Texas Vermiculite plant in West Dallas manufactured asbestos contaminated horticultural vermiculite for decades under trade name Terra Lite, as well as others. From the 1950s to 1992, this plant processed vermiculite from Libby, Montana for a variety of commercial purposes. What is vermiculite? Raw vermiculite ore, a naturally occurring mineral, …
Roswell Park Cancer Institute, in a partnership with Cuban researchers, has FDA approval for a phase I clinical study of CIMAvax, a new vaccine for lung cancer. This is an historic first in the modern era for such a partnership between Cuba and an American institution. In 2015, Gov. Cuomo brought a trade mission to …
